Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 67

Similar articles for PubMed (Select 23242536)

1.

A cluster of patients infected with I221V influenza b virus variants with reduced oseltamivir susceptibility--North Carolina and South Carolina, 2010-2011.

Garg S, Moore Z, Lee N, McKenna J, Bishop A, Fleischauer A, Springs CB, Nguyen HT, Sheu TG, Sleeman K, Finelli L, Gubareva L, Fry AM.

J Infect Dis. 2013 Mar 15;207(6):966-73. doi: 10.1093/infdis/jis776. Epub 2012 Dec 13.

2.

Influenza B viruses with mutation in the neuraminidase active site, North Carolina, USA, 2010-11.

Sleeman K, Sheu TG, Moore Z, Kilpatrick S, Garg S, Fry AM, Gubareva LV.

Emerg Infect Dis. 2011 Nov;17(11):2043-6. doi: 10.3201/eid1711.110787.

3.

Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.

Baranovich T, Saito R, Suzuki Y, Zaraket H, Dapat C, Caperig-Dapat I, Oguma T, Shabana II, Saito T, Suzuki H; Japanese Influenza Collaborative Study Group.

J Clin Virol. 2010 Jan;47(1):23-8. doi: 10.1016/j.jcv.2009.11.003. Epub 2009 Dec 3.

PMID:
19962344
4.

Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.

Meijer A, Jonges M, Abbink F, Ang W, van Beek J, Beersma M, Bloembergen P, Boucher C, Claas E, Donker G, van Gageldonk-Lafeber R, Isken L, de Jong A, Kroes A, Leenders S, van der Lubben M, Mascini E, Niesters B, Oosterheert JJ, Osterhaus A, Riesmeijer R, Riezebos-Brilman A, Schutten M, Sebens F, Stelma F, Swaan C, Timen A, van 't Veen A, van der Vries E, te Wierik M, Koopmans M.

Antiviral Res. 2011 Oct;92(1):81-9. doi: 10.1016/j.antiviral.2011.07.004. Epub 2011 Jul 13.

PMID:
21767571
5.

Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses.

Rath B, von Kleist M, Tief F, Karsch K, Tuerk E, Muehlhans S, Louis F, Skopnik H, Schweiger B, Duwe S.

Pediatr Infect Dis J. 2012 Sep;31(9):899-905. doi: 10.1097/INF.0b013e31825c7304.

PMID:
22581220
6.

Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.

Kawai N, Ikematsu H, Iwaki N, Kawashima T, Maeda T, Mitsuoka S, Kondou K, Satoh I, Miyachi K, Yamaga S, Shigematsu T, Hirotsu N, Kashiwagi S.

J Infect. 2007 Sep;55(3):267-72. Epub 2007 Jul 2.

PMID:
17604839
7.

Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Sep 11;58(35):969-72.

8.

Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.

Kawai N, Ikematsu H, Iwaki N, Kondou K, Hirotsu N, Kawashima T, Maeda T, Tanaka O, Doniwa K, Kashiwagi S.

J Infect. 2009 Sep;59(3):207-12. doi: 10.1016/j.jinf.2009.07.002. Epub 2009 Jul 7.

PMID:
19619898
9.
10.

Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan.

Yang JR, Huang YP, Lin YC, Su CH, Kuo CY, Hsu LC, Wu HS, Liu MT.

Antiviral Res. 2010 Dec;88(3):256-62. doi: 10.1016/j.antiviral.2010.09.014. Epub 2010 Sep 24.

PMID:
20869989
11.

Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children.

Sugaya N, Mitamura K, Yamazaki M, Tamura D, Ichikawa M, Kimura K, Kawakami C, Kiso M, Ito M, Hatakeyama S, Kawaoka Y.

Clin Infect Dis. 2007 Jan 15;44(2):197-202. Epub 2006 Dec 14.

12.

Influenza virus susceptibility and resistance to oseltamivir.

Aoki FY, Boivin G, Roberts N.

Antivir Ther. 2007;12(4 Pt B):603-16. Review.

PMID:
17944268
13.

Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.

Nguyen HT, Trujillo AA, Sheu TG, Levine M, Mishin VP, Shaw M, Ades EW, Klimov AI, Fry AM, Gubareva LV.

Antiviral Res. 2012 Mar;93(3):381-6. doi: 10.1016/j.antiviral.2012.01.006. Epub 2012 Feb 7.

PMID:
22330888
14.

Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.

Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, Liang ZA, Liang L, Zhang SJ, Zhang B, Gu L, Lu LH, Wang DY, Wang C; National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China.

N Engl J Med. 2009 Dec 24;361(26):2507-17. doi: 10.1056/NEJMoa0906612. Epub 2009 Dec 9.

15.

Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.

Kawai N, Ikematsu H, Hirotsu N, Maeda T, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Matsuura S, Nishimura M, Iwaki N, Kashiwagi S.

Clin Infect Dis. 2009 Dec 15;49(12):1828-35. doi: 10.1086/648424.

16.

Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.

Ledesma J, Vicente D, Pozo F, Cilla G, Castro SP, Fernández JS, Ruiz MP, Navarro JM, Galán JC, Fernández M, Reina J, Larrauri A, Cuevas MT, Casas I, Breña PP; Spanish Influenza Surveillance System (SISS).

J Clin Virol. 2011 Jul;51(3):205-8. doi: 10.1016/j.jcv.2011.04.008. Epub 2011 May 17.

PMID:
21592854
17.

Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation.

Saito R, Sato I, Suzuki Y, Baranovich T, Matsuda R, Ishitani N, Dapat C, Dapat IC, Zaraket H, Oguma T, Suzuki H.

Pediatr Infect Dis J. 2010 Oct;29(10):898-904. doi: 10.1097/INF.0b013e3181de9d24.

PMID:
20442686
18.

Virological surveillance and antiviral resistance of human influenza virus in Argentina, 2005-2008.

Pontoriero A, Baumeister E, Campos AM, Savy VL.

Rev Panam Salud Publica. 2011 Dec;30(6):634-40.

19.

Surveillance for neuraminidase-inhibitor-resistant influenza viruses in Japan, 1996-2007.

Tashiro M, McKimm-Breschkin JL, Saito T, Klimov A, Macken C, Zambon M, Hayden FG; Neuraminidase Inhibitor Susceptibility Network.

Antivir Ther. 2009;14(6):751-61. doi: 10.3851/IMP1194.

PMID:
19812437
20.

Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.

Duwe SC, Wedde M, Birkner P, Schweiger B.

Antiviral Res. 2011 Jan;89(1):115-8. doi: 10.1016/j.antiviral.2010.11.001. Epub 2010 Nov 9.

PMID:
21070812
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk